Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 41

1.

Physician's Knowledge of Appropriate Prescribing for the Elderly-A Survey Among Family and Internal Medicine Physicians in Nigeria.

Fadare JO, Obimakinde AM, Enwere OO, Desalu OO, Ibidapo RO.

Front Pharmacol. 2019 May 31;10:592. doi: 10.3389/fphar.2019.00592. eCollection 2019.

2.

Reported needs of information resources, research tools, connectivity and infrastructure among African Pharmacological Scientists to improve future patient care and health.

Ogunleye OO, Fadare JO, Eriksen J, Oaiya O, Massele A, Truter I, Taylor SJE, Godman B, Gustafsson LL.

Expert Rev Clin Pharmacol. 2019 May;12(5):481-489. doi: 10.1080/17512433.2019.1605903. Epub 2019 Apr 27.

PMID:
30961406
3.

Barriers for Access to New Medicines: Searching for the Balance Between Rising Costs and Limited Budgets.

Godman B, Bucsics A, Vella Bonanno P, Oortwijn W, Rothe CC, Ferrario A, Bosselli S, Hill A, Martin AP, Simoens S, Kurdi A, Gad M, Gulbinovič J, Timoney A, Bochenek T, Salem A, Hoxha I, Sauermann R, Massele A, Guerra AA Jr, Petrova G, Mitkova Z, Achniotou G, Laius O, Sermet C, Selke G, Kourafalos V, Yfantopoulos J, Magnusson E, Joppi R, Oluka M, Kwon HY, Jakupi A, Kalemeera F, Fadare JO, Melien O, Pomorski M, Wladysiuk M, Marković-Peković V, Mardare I, Meshkov D, Novakovic T, Fürst J, Tomek D, Zara C, Diogene E, Meyer JC, Malmström R, Wettermark B, Matsebula Z, Campbell S, Haycox A.

Front Public Health. 2018 Dec 5;6:328. doi: 10.3389/fpubh.2018.00328. eCollection 2018. Review.

4.

Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: Findings and implications.

Fadare JO, Ogunleye O, Iliyasu G, Adeoti A, Schellack N, Engler D, Massele A, Godman B.

J Glob Antimicrob Resist. 2019 Jun;17:132-136. doi: 10.1016/j.jgar.2018.11.025. Epub 2018 Dec 14.

PMID:
30557686
5.

Drug and therapeutics committees in Nigeria: evaluation of scope and functionality.

Fadare JO, Ogunleye O, Obiako R, Orubu S, Enwere O, Ajemigbitse AA, Meyer JC, Enato E, Massele A, Godman B, Gustafsson LL.

Expert Rev Clin Pharmacol. 2018 Dec;11(12):1255-1262. doi: 10.1080/17512433.2018.1549488. Epub 2018 Nov 30.

PMID:
30451035
6.

Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital.

Ogunleye OO, Fadare JO, Yinka-Ogunleye AF, Anand Paramadhas BD, Godman B.

Hosp Pract (1995). 2019 Feb;47(1):53-58. doi: 10.1080/21548331.2018.1475997. Epub 2018 May 21.

PMID:
29757036
7.

Drug promotional activities in Nigeria: impact on the prescribing patterns and practices of medical practitioners and the implications.

Fadare JO, Oshikoya KA, Ogunleye OO, Desalu OO, Ferrario A, Enwere OO, Adeoti A, Sunmonu TA, Massele A, Baker A, Godman B.

Hosp Pract (1995). 2018 Apr;46(2):77-87. doi: 10.1080/21548331.2018.1437319. Epub 2018 Feb 20.

8.

Medication adherence and adverse effect profile of antiepileptic drugs in Nigerian patients with epilepsy.

Fadare JO, Sunmonu TA, Bankole IA, Adekeye KA, Abubakar SA.

Neurodegener Dis Manag. 2018 Feb;8(1):25-36. doi: 10.2217/nmt-2017-0044. Epub 2018 Jan 8.

PMID:
29308710
9.

Bronchoscopy in Nigerian Clinical Practice: A Survey of Medical Doctors' Perception, Use and Associated Challenges.

Adeoti AO, Desalu OO, Fadare JO, Alaofin W, Onyedum CC.

Ethiop J Health Sci. 2017 Jul;27(4):331-338.

10.

Identifying patients at high risk for obstructive sleep apnoea syndrome in Nigeria: A multicentre observational study.

Desalu OO, Onyedum CC, Adeoti AO, Fadare JO, Sanya EO, Fawale MB, Bello HA.

Malawi Med J. 2017 Jun;29(2):183-188.

11.

Non-guideline-recommended prescribing of proton pump inhibitors: implications for the future and reducing over usage.

Godman B, Fadare J.

Curr Med Res Opin. 2017 Nov;33(11):2085-2087. doi: 10.1080/03007995.2017.1358159. Epub 2017 Aug 16.

12.

Patterns of drugs prescribed for dental outpatients in Nigeria: findings and implications.

Fadare JO, Oshikoya KA, Obimakinde OS, Sijuade AO, Afolayan JM, Adeleke AA, Godman B, Ojumu DO.

Acta Odontol Scand. 2017 Oct;75(7):496-506. doi: 10.1080/00016357.2017.1347822. Epub 2017 Jul 11.

13.

Off-label prescribing for children with chronic diseases in Nigeria; findings and implications.

Oshikoya KA, Oreagba IA, Godman B, Fadare J, Orubu S, Massele A, Senbanjo IO.

Expert Opin Drug Saf. 2017 Sep;16(9):981-988. doi: 10.1080/14740338.2017.1344639. Epub 2017 Jul 10.

14.

Self-medication among health workers in a tertiary institution in South-West Nigeria.

Babatunde OA, Fadare JO, Ojo OJ, Durowade KA, Atoyebi OA, Ajayi PO, Olaniyan T.

Pan Afr Med J. 2016 Aug 16;24:312. doi: 10.11604/pamj.2016.24.312.8146. eCollection 2016.

15.

Quality of acute asthma care in two tertiary hospitals in a state in South Western Nigeria: A report of clinical audit.

Desalu OO, Adeoti AO, Ogunmola OJ, Fadare JO, Kolawole TF.

Niger Med J. 2016 Nov-Dec;57(6):339-346.

16.

Adverse effects of carbamazepine monotherapy among patients in Nigeria: a pilot study and implications.

Olusanya A, Ogunleye O, Godman B, Fadare J, Danesi M.

J Comp Eff Res. 2017 Jan;6(1):33-42. doi: 10.2217/cer-2016-0057. Epub 2016 Dec 12.

17.

Knowledge and use of asthma control measurement tools in the management of asthma: a survey of doctors working in family and internal medicine practice in Nigeria.

Desalu OO, Onyedum CC, Adeoti AO, Ozoh OB, Fadare JO.

Afr Health Sci. 2016 Jun;16(2):480-9. doi: 10.4314/ahs.v16i2.16.

18.

Potential drug-drug interactions in paediatric outpatient prescriptions in Nigeria and implications for the future.

Oshikoya KA, Oreagba IA, Godman B, Oguntayo FS, Fadare J, Orubu S, Massele A, Senbanjo IO.

Expert Rev Clin Pharmacol. 2016 Nov;9(11):1505-1515. doi: 10.1080/17512433.2016.1232619. Epub 2016 Sep 21.

19.

Prevalence, Awareness and Reporting of Symptoms of Obstructive Sleep Apnoea among Hospitalized Adult Patients in Nigeria: A Multicenter Study.

Desalu O, Onyedum C, Sanya E, Fadare J, Adeoti A, Salawu F, Oluyombo R, Olamoyegun M, Fawale M, Gbadegesin B, Bello H.

Ethiop J Health Sci. 2016 Jul;26(4):321-30.

20.

Introduction and Utilization of High Priced HCV Medicines across Europe; Implications for the Future.

de Bruijn W, Ibáñez C, Frisk P, Bak Pedersen H, Alkan A, Vella Bonanno P, Brkičić LS, Bucsics A, Dedet G, Eriksen J, Fadare JO, Fürst J, Gallego G, Godói IP, Guerra Júnior AA, Gürsöz H, Jan S, Jones J, Joppi R, Kerman S, Laius O, Madzikwa N, Magnússon E, Maticic M, Markovic-Pekovic V, Massele A, Ogunleye O, O'Leary A, Piessnegger J, Sermet C, Simoens S, Tiroyakgosi C, Truter I, Thyberg M, Tomekova K, Wladysiuk M, Vandoros S, Vural EH, Zara C, Godman B.

Front Pharmacol. 2016 Jul 22;7:197. doi: 10.3389/fphar.2016.00197. eCollection 2016.

Supplemental Content

Loading ...
Support Center